Avagenesis Corp. Expands Licenced Technology to New Stem Cell Therapy Markets – MarketWatch
|
Avagenesis Corp. Expands Licenced Technology to New Stem Cell Therapy Markets
MarketWatch Under the terms of the Amended Agreement, the Licensor has expanded an exclusive worldwide license (except China) to develop and commercialize the Licensors Enrichment Technology for the production of biologically active stem cell candidates in the … |
